Stefan Zeuzem Selected Research

Hepatitis B

1/2023	A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
4/2022	[Treatment of parenterally transmittable viral hepatitis].
12/2019	Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection.
4/2016	Pre- and Post-Transplant Antiviral Therapy (HBV, HCV).
3/2015	Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.
1/2014	Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
12/2013	Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: a prospective, observational, multicenter study.
10/2013	Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.
1/2012	A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers.
3/2007	Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Zeuzem Research Topics

Disease

207	Infections 03/2024 - 04/2002
170	Chronic Hepatitis C 01/2023 - 10/2002
111	Fibrosis (Cirrhosis) 03/2024 - 07/2003
78	Hepatitis C 12/2022 - 04/2002
50	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 01/2008
44	Liver Diseases (Liver Disease) 03/2024 - 09/2006
41	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 11/2007
38	Neoplasms (Cancer) 08/2023 - 02/2002
34	Chronic Hepatitis B 01/2023 - 04/2002
17	Virus Diseases (Viral Diseases) 01/2023 - 10/2006
14	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 02/2002
14	Hepatitis B 01/2023 - 06/2003
13	Inflammation (Inflammations) 01/2023 - 10/2006
12	Hepatitis D 10/2023 - 01/2011
12	End Stage Liver Disease 04/2023 - 09/2012
12	Viremia 05/2014 - 04/2002
11	Hemorrhage 09/2023 - 01/2013
11	Fatigue 01/2022 - 01/2003
11	Anemia 03/2016 - 04/2009
10	Acute-On-Chronic Liver Failure 01/2024 - 08/2018
10	Pathologic Constriction (Stenosis) 10/2023 - 03/2013
10	Body Weight (Weight, Body) 05/2014 - 06/2004
9	Coinfection 01/2020 - 11/2008
7	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2008
7	Hepatitis 04/2023 - 11/2004
7	Ascites 01/2023 - 09/2012
7	Liver Failure 01/2018 - 11/2007
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 11/2004
6	Insulin Resistance 08/2020 - 12/2010
6	Exanthema (Rash) 03/2016 - 04/2009
5	Cholangiocarcinoma 08/2023 - 02/2017
5	Chronic Hepatitis D 07/2023 - 03/2010
5	Liver Neoplasms (Liver Cancer) 01/2023 - 06/2013

Drug/Important Bio-Agent (IBA)

137	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 12/2002
126	Antiviral Agents (Antivirals)IBA 03/2024 - 04/2002
98	InterferonsIBA 04/2023 - 10/2002
52	RNA (Ribonucleic Acid)IBA 07/2023 - 10/2002
34	Interferon-alpha (Interferon Alfa)IBA 01/2023 - 04/2002
33	SofosbuvirIBA 03/2024 - 05/2014
29	Protease Inhibitors (Protease Inhibitor)IBA 12/2018 - 09/2007
29	telaprevirIBA 03/2016 - 10/2006
22	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2004
22	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2010
22	Hepatitis B e AntigensIBA 01/2023 - 01/2005
22	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 10/2002
14	Alanine Transaminase (SGPT)IBA 04/2023 - 12/2004
14	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2002
12	velpatasvirIBA 03/2024 - 12/2015
12	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 11/2008
12	Lamivudine (Epivir)FDA Link 02/2009 - 04/2002
11	daclatasvirIBA 01/2018 - 10/2014
11	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2016 - 04/2007
10	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 09/2011
10	SphingolipidsIBA 01/2023 - 07/2014
10	MicroRNAs (MicroRNA)IBA 10/2020 - 05/2012
10	SimeprevirIBA 01/2019 - 06/2012
9	BilirubinIBA 11/2021 - 12/2009
9	NucleosidesIBA 08/2016 - 08/2007
9	faldaprevirIBA 08/2016 - 12/2011
8	Tenofovir (Viread)FDA Link 10/2023 - 01/2013
8	grazoprevirIBA 01/2022 - 07/2015
8	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 07/2008
8	ledipasvirIBA 11/2018 - 05/2014
8	Vitamin D FDA LinkGeneric 10/2018 - 05/2011
8	EnzymesIBA 01/2018 - 11/2004
8	sofosbuvir drug combination ledipasvirIBA 01/2018 - 05/2014
8	Interferon alpha-2 (Roferon-A)FDA Link 09/2012 - 12/2002
7	C-Reactive ProteinIBA 01/2023 - 05/2013
7	glecaprevir and pibrentasvirIBA 01/2022 - 10/2017
7	elbasvirIBA 01/2022 - 07/2015
7	AlbuminsIBA 11/2021 - 12/2007
7	Peptide Hydrolases (Proteases)FDA Link 10/2020 - 10/2006
7	CholesterolIBA 07/2018 - 04/2006
7	hydroxide ionIBA 01/2018 - 06/2009
7	deleobuvirIBA 08/2016 - 12/2011
7	Telbivudine FDA Link 01/2016 - 12/2007
6	CytokinesIBA 01/2021 - 01/2005
6	LipidsIBA 08/2020 - 04/2006
6	Ritonavir (Norvir)FDA Link 11/2019 - 01/2014
6	NucleotidesIBA 01/2017 - 08/2007
6	Indicators and Reagents (Reagents)IBA 10/2016 - 11/2004
6	Amantadine (Aman)FDA LinkGeneric 01/2013 - 06/2003
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 06/2014
5	paritaprevirIBA 11/2019 - 01/2014
5	Triglycerides (Triacylglycerol)IBA 07/2018 - 07/2003
5	ombitasvirIBA 01/2018 - 01/2014
5	adefovirIBA 12/2015 - 08/2005
5	peginterferon alfa-2b (Pegintron)FDA Link 11/2011 - 06/2004
5	adefovir dipivoxil (Hepsera)FDA Link 09/2011 - 12/2003

Therapy/Procedure

214	Therapeutics 02/2024 - 04/2002
38	Liver Transplantation 11/2023 - 06/2003
12	Drug Therapy (Chemotherapy) 08/2023 - 01/2011
10	Stents 10/2023 - 01/2014
10	Aftercare (After-Treatment) 05/2018 - 08/2007
9	Duration of Therapy 01/2017 - 03/2004
6	Retreatment 01/2021 - 03/2011
5	Lasers (Laser) 04/2024 - 12/2014
5	Antibiotic Prophylaxis 04/2023 - 01/2020
5	Transplantation 08/2022 - 02/2007
5	Drug Tapering 06/2015 - 02/2009